4.4 Article

ALTERED MEF2 ISOFORMS IN MYOTONIC DYSTROPHY AND OTHER NEUROMUSCULAR DISORDERS

期刊

MUSCLE & NERVE
卷 42, 期 6, 页码 856-863

出版社

WILEY
DOI: 10.1002/mus.21789

关键词

dysregulation; MADS-domain transcription enhancer factor 2; MEF2; myotonic dystrophy; splicing

资金

  1. University of Texas M.D. Anderson Cancer Center's University Cancer Foundation
  2. NIH [AR48171]
  3. Muscular Dystrophy Association USA
  4. Kleberg Foundation
  5. Folkhalsan Research Foundation
  6. Liv and Halsa Foundation
  7. Vasa Central Hospital District
  8. Kung Gustav V Adolfs och Drottning Victorias Minnesfond Foundation

向作者/读者索取更多资源

Because of their central role in muscle development and maintenance, MEF2 family members represent excellent candidate effectors of the muscle pathology in myotonic dystrophy (DM). We investigated the expression and alternative splicing of all four MEF2 genes in muscle from neuromuscular disorder (NMD) patients, including DM1 and DM2. We observed MEF2A and MEF2C overexpression in all NMD muscle, including 12 MEF2-interacting genes. Exon 4 and 5 usage in MEF2A and MEF2C was different between DM and normal muscle, with DM showing the embryonic isoform. Similar splicing differences were observed in other NMD muscle. For MEF2C, missplicing was more pronounced in DM than in other dystrophies. Our data confirm dysregulation of MEF2A and MEF2C expression and splicing in several NMD, including DM. Our findings demonstrate that aberrant splicing in NMD is independent from expression of mutant repeats, and suggests that some aberrant splicing, even in DM, may be compensatory rather than primary. Muscle Nerve 42: 856-863,2010

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据